417 related articles for article (PubMed ID: 8258907)
1. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
3. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.
Newsom-Davis J; Willcox N; Calder L
N Engl J Med; 1981 Nov; 305(22):1313-8. PubMed ID: 7290153
[TBL] [Abstract][Full Text] [Related]
4. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
Williams CL; Hay JE; Huiatt TW; Lennon VA
Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
[TBL] [Abstract][Full Text] [Related]
7. Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1983 Nov; 54(2):378-86. PubMed ID: 6317238
[TBL] [Abstract][Full Text] [Related]
8. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholine receptor antibody synthesis in lymphocyte cultures.
McLachlan SM; Nicholson LV; Venables G; Mastalgia FL; Bates D; Smith BR; Hall R
J Clin Lab Immunol; 1981 May; 5(3):137-42. PubMed ID: 7241564
[TBL] [Abstract][Full Text] [Related]
10. B- and T-cell activation in the thymus of patients with myasthenia gravis.
Cohen-Kaminsky S; Leprince C; Galanaud P; Richards Y; Berrih-Aknin S
Thymus; 1989; 14(1-3):187-93. PubMed ID: 2623739
[TBL] [Abstract][Full Text] [Related]
11. The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis.
Thangarajh M; Masterman T; Helgeland L; Rot U; Jonsson MV; Eide GE; Pirskanen R; Hillert J; Jonsson R
J Neuroimmunol; 2006 Sep; 178(1-2):161-6. PubMed ID: 16820216
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma.
Ishii W; Matsuda M; Hanyuda M; Momose M; Nakayama J; Ehara T; Ikeda S
J Clin Neurosci; 2007 Feb; 14(2):110-5. PubMed ID: 17113295
[TBL] [Abstract][Full Text] [Related]
13. The thymus in myasthenia gravis. Evidence for altered cell populations.
Abdou NI; Lisak RP; Zweiman B; Abrahamsohn I; Penn AS
N Engl J Med; 1974 Dec; 291(24):1271-5. PubMed ID: 4279335
[No Abstract] [Full Text] [Related]
14. [Thymus gland pathology in myasthenia gravis: cause or consequence?].
Zaĭrat'iants OV; Vetshev PS; Khavinson VKh; Ippolitov IKh; Shakhova OV
Sov Med; 1990; (8):18-25. PubMed ID: 2274814
[TBL] [Abstract][Full Text] [Related]
15. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
16. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
Zhang J; Zhou WB; Wang HL; Guo SS
Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
[TBL] [Abstract][Full Text] [Related]
17. Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects.
Willcox N; Schluep M; Sommer N; Campana D; Janossy G; Brown AN; Newsom-Davis J
Q J Med; 1989 Nov; 73(271):1071-87. PubMed ID: 2623139
[TBL] [Abstract][Full Text] [Related]
18. Letter: B lymphocytes in the thymus of patients with myasthenia gravis.
Staber FG; Fink U; Sack W
N Engl J Med; 1975 May; 292(19):1032-3. PubMed ID: 1078872
[No Abstract] [Full Text] [Related]
19. Receptors for IgA on human thymus cells in myasthenia gravis.
Moraru I; Mota G; Juvara I; Dobre MA; Galatiuc C; Ghetie V
Clin Exp Immunol; 1982 Apr; 48(1):129-36. PubMed ID: 6805991
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
